tyrosine kinase inhibitors
At present, tyrosine kinase inhibitors (TKI) became the gold standard in treatment of chronic myeloid leukemia (CML) and have certain effects on the quality of life (QoL) due to prolonged treatment period.
At present, tyrosine kinase inhibitors ( TKI ) became the gold standard in treatment of chronic myeloid leukemia ( CML ) and have certain effects on the quality of life ( QoL ) due to prolonged treatment period .